KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Acadia Pharmaceuticals (ACAD) Shares Outstanding (Diluted Average) (2020 - 2025)

Acadia Pharmaceuticals has reported Shares Outstanding (Diluted Average) over the past 9 years, most recently at $169.9 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Diluted Average) at $169.9 million for Q4 2025, up 2.14% from a year ago — trailing twelve months through Dec 2025 was $169.9 million (up 2.14% YoY), and the annual figure for FY2025 was $169.9 million, up 2.14%.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $169.9 million at Acadia Pharmaceuticals, roughly flat from $170.6 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for ACAD hit a ceiling of $170.6 million in Q3 2025 and a floor of $160421.0 in Q2 2021.
  • Median Shares Outstanding (Diluted Average) over the past 5 years was $163.8 million (2023), compared with a mean of $113.3 million.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): skyrocketed 101998.31% in 2023 and later tumbled 99.9% in 2025.
  • Acadia Pharmaceuticals' Shares Outstanding (Diluted Average) stood at $160493.0 in 2021, then surged by 100641.47% to $161.7 million in 2022, then increased by 1.32% to $163.8 million in 2023, then increased by 1.55% to $166.4 million in 2024, then rose by 2.14% to $169.9 million in 2025.
  • The last three reported values for Shares Outstanding (Diluted Average) were $169.9 million (Q4 2025), $170.6 million (Q3 2025), and $168219.0 (Q2 2025) per Business Quant data.